Advertisement Geospiza, NuGEN in pact to accelerate discoveries for research studies - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Geospiza, NuGEN in pact to accelerate discoveries for research studies

Geospiza and NuGEN Technologies have entered into a co-marketing agreement for the development of a next-generation sequencing workflow to accelerate discoveries for large disease research studies.

Geospiza is the developer of GeneSifter software, that offers integrated solutions for Next Generation Sequencing analysis and LIMS.

Geospiza president Rob Arnold said Geospiza’s lab and analysis software tools are focused on making research easier, faster and more cost effective.

Combining our GeneSifter preconfigured lab and analysis cloud software with NuGEN’s Ovationand Encore reagents enables researchers to follow and document a step-by-step best practice for sample preparation combined with fully integrated data analysis and other sample information in one system," Arnold said.